Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C V Caballero-Uribe

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Rheumatology (Oxford, England)|September 28, 2004
The fibromyalgia problem. A Latin American point of viewC V Caballero-Uribe
British Journal of Rheumatology|February 1, 1997
Getting to know about ColombiaC V Caballero-Uribe
Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association|October 8, 1999
Why is methotrexate the first selection in disease-modifying antirheumatic drug therapy? Comment on the article by Wolfe et alC V Caballero-Uribe
Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association|June 1, 1997
Measurement of depression in Mexican patients with rheumatoid arthritis: validity of the Beck Depression InventoryA A Suárez-Mendoza, M H Cardiel, C V Caballero-Uribe, et al.
Rheumatology (Oxford, England)|May 9, 2008
Use of rituximab for the treatment of rheumatoid arthritis: the Latin American contextE R Soriano, C Galarza-Maldonado, M H Cardiel, et al.
Clinical Rheumatology|March 28, 2019
PANLAR consensus statement on biosimilarsS C Kowalski, J A Benavides, P A B Roa, et al.
Clinical Rheumatology|May 22, 2019
Correction to: PANLAR consensus statement on biosimilarsS C Kowalski, J A Benavides, P A Beltrán, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Rheumatology (Oxford, England)|September 28, 2004
The fibromyalgia problem. A Latin American point of viewC V Caballero-Uribe
British Journal of Rheumatology|February 1, 1997
Getting to know about ColombiaC V Caballero-Uribe
Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association|October 8, 1999
Why is methotrexate the first selection in disease-modifying antirheumatic drug therapy? Comment on the article by Wolfe et alC V Caballero-Uribe
Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association|June 1, 1997
Measurement of depression in Mexican patients with rheumatoid arthritis: validity of the Beck Depression InventoryA A Suárez-Mendoza, M H Cardiel, C V Caballero-Uribe, et al.
Rheumatology (Oxford, England)|May 9, 2008
Use of rituximab for the treatment of rheumatoid arthritis: the Latin American contextE R Soriano, C Galarza-Maldonado, M H Cardiel, et al.
Clinical Rheumatology|March 28, 2019
PANLAR consensus statement on biosimilarsS C Kowalski, J A Benavides, P A B Roa, et al.
Clinical Rheumatology|May 22, 2019
Correction to: PANLAR consensus statement on biosimilarsS C Kowalski, J A Benavides, P A Beltrán, et al.
Pageof 1